News

Carterra CEO, Josh Eckman, Recognized as a Rising Star by the David Eccles School of Business

Carterra^® Inc., a provider of innovative drug discovery technologies, announced that its CEO, Josh Eckman, has been honored as a Rising Star by The University of Utah David Eccles School of Business during its 2018 Hall of Fame induction ceremony.

Read More

LakePharma Expands Service Capability with Purchase of Carterra High Throughput Antibody Characterization LSA™ Instrumentation

First Contract Development & Manufacturing Organization to Install Carterra’s Next Generation Label-Free Biosensor to Support Antibody Discovery Services Business

Read More

Institute for Protein Innovation Buys Carterra Next-Generation Antibody Characterization LSA™ Instrumentation

First Research Institution to Purchase Carterra’s High-Throughput Label-Free Biosensor to Support its Novel Antibody Discovery

Read More

Carterra Announces Multiple Sales of its New LSA™ Array SPR Instrument for Comprehensive Monoclonal Antibody Characterization

First LSA instrument sales are to a broad range of initial customers, including large pharmaceutical, biotech, CRO and academic institutions.

Read More

Carterra Inc. Raises $10M from Telegraph Hill Partners to Develop and Launch Next-Generation Antibody Characterization Platform

Additional Resources Will Drive Commercialization of Novel High-Throughput Label-Free Biosensor for Streamlined Antibody Characterization.

Read More

GEN Tutorial on High Throughput Antibody Characterization

Learn about epitope binning for next-generation biotherapeutic discovery.

Read More

Wasatch Microfluidics Announces Name Change to Carterra Inc. and New High Throughput SPR Instrument

New corporate name and system reflect the evolution of the Company into a premier provider of biotherapeutic characterization tools.

Read More